Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact ir@baincapital.com.
Stada set a record with production volume increased by 10% in March, resulting in the output of more than 1.2 billion individual units of critical cancer therapies, transplantation drugs and cardiovascular medicines for essential treatment, as well as ibuprofen and cold medicines.
STADA is adopting a localized, targeted strategy to support the fight against COVID-19 by donating critical medical supplies across 12 countries in Europe. Among the donations are 50,000 masks to Doctors Without Borders, 150 patient monitors to facilities in Serbia, Bosnia and Montenegro, €500,000 of essential medicines such as antibiotics and antihypertensives for Russian hospitals, and 23,000 first aid packs to hospitals, medical facilities and pharmacies in Spain.
STADA (SAZ:GR) is a leading European manufacturer of prescription generics and over-the-counter medicine, with a presence across more than 120 markets and leading positions in key countries.
Hit enter to search or ESC to close